C-locked analogs of the antimicrobial peptide BP214
Research output: Contribution to journal › Journal article › peer-review
Documents
- Fulltext
Final published version, 818 KB, PDF document
BP214 is an all-D antimicrobial peptide amide, kklfkkilryl, which shows an excellent activity against colistin-resistant Acinetobacter baumannii and a low hemolytic activity. The aim of the present work was to investigate how C-terminus-to-side chain macrocyclization and fatty acid modification affect the antimicrobial and hemolytic activity of this peptide. In total, 18 analogs of BP214 were synthesized using a combination of Fmoc-based solid-phase peptide synthesis and the submonomer approach. Cyclization was achieved by reacting the ε-amino group of a C-terminal lysine residue with a bromoacetylgroup attached to the Nα amino group of the N-terminal amino acid, generating a secondary amine at which the exocyclic lipopeptide tail was assembled. Three different ring sizes (i.e., 3-5 amino acid residues) of C-locked analogs combined with fatty acids of different lengths (i.e., C10-C14) were investigated. The antimicrobial activity of the analogs was tested against Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa. The most promising compound was analog 13 (MIC = 4 µg/mL (2.4 µM) against E. coli and 36% hemolysis of red blood cells at 150 µM). In a time-kill assay, this peptide showed a significant, concentration-dependent reduction in viable E. coli cells comparable to that seen for colistin.
Original language | English |
---|---|
Article number | 1080 |
Journal | Antibiotics |
Volume | 11 |
Issue number | 8 |
Number of pages | 10 |
ISSN | 2079-6382 |
DOIs | |
Publication status | Published - 2022 |
Bibliographical note
This article belongs to the Special Issue Peptide-Based Antibiotics: Challenges and Opportunities.
Number of downloads are based on statistics from Google Scholar and www.ku.dk
No data available
ID: 312112456